Timentin
- CAS No.
- 86482-18-0
- Chemical Name:
- Timentin
- Synonyms
- Temetine;TIMENTIN;TIMENTIN;TIMENTIN;TIMENTIN;ticarcillin-clavulanic acid;(2S,5R,6R)-6-[[(2R)-2-carboxy-2-thiophen-3-ylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2S,5R,6R)-6-[[(2R)-2-carboxy-2-thiophen-3-ylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid:(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- CBNumber:
- CB91381965
- Molecular Formula:
- C15H16N2O6S2.C8H9NO5
- Molecular Weight:
- 583.593
- MOL File:
- 86482-18-0.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/7/2 8:55:40
Timentin Chemical Properties,Uses,Production
Antimicrobial activity
Activity is that of ticarcillin , the role of the inhibitor being to restore the activity against β-lactamase-producing strains that would otherwise hydrolyze the drug.
Pharmacokinetics
Cmax 3 g ticarcillin + 100 mg: 330 mg/L end: 8 mg/L end
clavulanate intravenous: infusion:
infusion
infusion (30 min)
Plasma half-life: 1.1 h 1.1 h
Plasma protein binding: 45% 25%
The pharmacokinetics of the two agents are mutually
unaffected
by co-administration. Ticarcillin can be detected
in tissues and interstitial fluid following parenteral administration.
Penetration into bile, peritoneal fluid and pleural fluid
has been demonstrated. Concentrations in blister fluid were
significantly lower than those in serum.
Around 60–70% of ticarcillin and 35–45% of clavulanic
acid are excreted unchanged in urine during the first 6 h after
administration of a single dose of the mixture.
Clinical Use
Septicemia, including bacteremia
Lower respiratory infections
Bone and joint infections
Skin and skin structure infections
Urinary tract infections (complicated and uncomplicated)
Gynecological infections, endometritis
Intra-abdominal infections, peritonitis
Its main use is in infections in which Ps. aeruginosa is suspected
or proven.
Side effects
Adverse reactions associated with ticarcillin occur . As with co-amoxiclav, there is a risk of cholestatic jaundice . Pseudomembranous colitis has been reported.
Timentin Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| Kritikos Care | 08047645075 | Haryana, India | 1 | 58 | Inquiry |
| Career Henan Chemica Co | +86-0371-86658258 +8613203830695 | China | 30253 | 58 | Inquiry |
| Shanghai Acmec Biochemical Technology Co., Ltd. | +undefined18621343501 | China | 33350 | 58 | Inquiry |
| Anhui kuer Bioengineering Co., Ltd | 0551-65171243 13810511747 | China | 2997 | 55 | Inquiry |
| Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. | 025-66113011 18112977050 | China | 10529 | 58 | Inquiry |
| Shanghai Zheyan Biotechnology Co., LTD | 18017610038 18017610038 | China | 5000 | 58 | Inquiry |
| Hunan Revel Biotechnology Co. , Ltd. | 19359985961 19359985961 | China | 1272 | 58 | Inquiry |
| Shanghai Macklin Biochemical Co.,Ltd. | 15221275939 15221275939 | China | 16168 | 55 | Inquiry |
| Wuhan Dingxintong Pharmaceutical Co. , Ltd. | 027-83984790 17720532645 | China | 1000 | 58 | Inquiry |
| Pand (Shanghai) international trade Co., LTD | 021-80159919 18662931292 | China | 5000 | 58 | Inquiry |
Related articles
- Ticarcillin–Clavulanic Acid: Clinical Uses and Toxicity
- Since its introduction for clinical use, ticarcillin–clavulanate has been used for a variety of clinical infections because of....
- Mar 21，2022
- Ticarcillin–Clavulanic Acid: Antimicrobial Activity, Susceptibility, Administration and Dosage etc.
- Ticarcillin–clavulanate is an injectable antibacterial combination consisting of two agents, a beta-lactam antibiotic (ticarci....
- Mar 21，2022